Global Tofacitinib Tablets Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tofacitinib Tablets Market Insights, Forecast to 2034

Tofacitinib, also known as Xeljanz, is a type of drug known as a Janus kinase (JAK) inhibitor. It works by blocking the action of Janus kinase enzymes, which are involved in the inflammation that causes the symptoms of rheumatoid arthritis and psoriatic arthritis.
Global Tofacitinib Tablets market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Tofacitinib Tablets industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Tofacitinib Tablets key manufacturers include Pfizer, Globe Pharmaceuticals, Delta Pharma Limited, Beacon Pharmaceuticals and Drug International, etc. Pfizer, Globe Pharmaceuticals, Delta Pharma Limited are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Tofacitinib Tablets were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Tofacitinib Tablets market and estimated to attract more attentions from industry insiders and investors.
Tofacitinib Tablets can be divided into 5mg*60 Tablets, 5mg*10 Tablets, 10mg*10 Tablets and 5mg*30 Tablets, etc. 5mg*60 Tablets is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Tofacitinib Tablets is widely used in various fields, such as Rheumatoid Arthritis, Ulcerative Colitis, Psoriasis and Other, etc. Rheumatoid Arthritis provides greatest supports to the Tofacitinib Tablets industry development. In 2022, global % sales of Tofacitinib Tablets went into Rheumatoid Arthritis filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Tofacitinib Tablets market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Tofacitinib Tablets market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report

By Company

Pfizer
Globe Pharmaceuticals
Delta Pharma Limited
Beacon Pharmaceuticals
Drug International
Segment by Type
5mg*60 Tablets
5mg*10 Tablets
10mg*10 Tablets
5mg*30 Tablets
5mg*14 Tablets
10mg*14 Tablets

Segment by Application

Rheumatoid Arthritis
Ulcerative Colitis
Psoriasis
Other

Segment by Region

US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline

Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Tofacitinib Tablets plant distribution, commercial date of Tofacitinib Tablets, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Tofacitinib Tablets introduction, etc. Tofacitinib Tablets Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Tofacitinib Tablets
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Tofacitinib Tablets Product Introduction
1.2 Market by Type
1.2.1 Global Tofacitinib Tablets Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 5mg60 Tablets
1.2.3 5mg10 Tablets
1.2.4 10mg10 Tablets
1.2.5 5mg30 Tablets
1.2.6 5mg14 Tablets
1.2.7 10mg14 Tablets
1.3 Market by Application
1.3.1 Global Tofacitinib Tablets Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Rheumatoid Arthritis
1.3.3 Ulcerative Colitis
1.3.4 Psoriasis
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tofacitinib Tablets Sales Estimates and Forecasts 2018-2029
2.2 Global Tofacitinib Tablets Revenue by Region
2.2.1 Global Tofacitinib Tablets Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Tofacitinib Tablets Revenue by Region (2018-2024)
2.2.3 Global Tofacitinib Tablets Revenue by Region (2024-2029)
2.2.4 Global Tofacitinib Tablets Revenue Market Share by Region (2018-2029)
2.3 Global Tofacitinib Tablets Sales Estimates and Forecasts 2018-2029
2.4 Global Tofacitinib Tablets Sales by Region
2.4.1 Global Tofacitinib Tablets Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Tofacitinib Tablets Sales by Region (2018-2024)
2.4.3 Global Tofacitinib Tablets Sales by Region (2024-2029)
2.4.4 Global Tofacitinib Tablets Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Tofacitinib Tablets Sales by Manufacturers
3.1.1 Global Tofacitinib Tablets Sales by Manufacturers (2018-2024)
3.1.2 Global Tofacitinib Tablets Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tofacitinib Tablets in 2022
3.2 Global Tofacitinib Tablets Revenue by Manufacturers
3.2.1 Global Tofacitinib Tablets Revenue by Manufacturers (2018-2024)
3.2.2 Global Tofacitinib Tablets Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Tofacitinib Tablets Revenue in 2022
3.3 Global Key Players of Tofacitinib Tablets, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Tofacitinib Tablets Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Tofacitinib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Tofacitinib Tablets, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Tofacitinib Tablets, Product Offered and Application
3.8 Global Key Manufacturers of Tofacitinib Tablets, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tofacitinib Tablets Sales by Type
4.1.1 Global Tofacitinib Tablets Historical Sales by Type (2018-2024)
4.1.2 Global Tofacitinib Tablets Forecasted Sales by Type (2024-2029)
4.1.3 Global Tofacitinib Tablets Sales Market Share by Type (2018-2029)
4.2 Global Tofacitinib Tablets Revenue by Type
4.2.1 Global Tofacitinib Tablets Historical Revenue by Type (2018-2024)
4.2.2 Global Tofacitinib Tablets Forecasted Revenue by Type (2024-2029)
4.2.3 Global Tofacitinib Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Tofacitinib Tablets Price by Type
4.3.1 Global Tofacitinib Tablets Price by Type (2018-2024)
4.3.2 Global Tofacitinib Tablets Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Tofacitinib Tablets Sales by Application
5.1.1 Global Tofacitinib Tablets Historical Sales by Application (2018-2024)
5.1.2 Global Tofacitinib Tablets Forecasted Sales by Application (2024-2029)
5.1.3 Global Tofacitinib Tablets Sales Market Share by Application (2018-2029)
5.2 Global Tofacitinib Tablets Revenue by Application
5.2.1 Global Tofacitinib Tablets Historical Revenue by Application (2018-2024)
5.2.2 Global Tofacitinib Tablets Forecasted Revenue by Application (2024-2029)
5.2.3 Global Tofacitinib Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Tofacitinib Tablets Price by Application
5.3.1 Global Tofacitinib Tablets Price by Application (2018-2024)
5.3.2 Global Tofacitinib Tablets Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Tofacitinib Tablets Market Size by Type
6.1.1 US & Canada Tofacitinib Tablets Sales by Type (2018-2029)
6.1.2 US & Canada Tofacitinib Tablets Revenue by Type (2018-2029)
6.2 US & Canada Tofacitinib Tablets Market Size by Application
6.2.1 US & Canada Tofacitinib Tablets Sales by Application (2018-2029)
6.2.2 US & Canada Tofacitinib Tablets Revenue by Application (2018-2029)
6.3 US & Canada Tofacitinib Tablets Market Size by Country
6.3.1 US & Canada Tofacitinib Tablets Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Tofacitinib Tablets Sales by Country (2018-2029)
6.3.3 US & Canada Tofacitinib Tablets Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Tofacitinib Tablets Market Size by Type
7.1.1 Europe Tofacitinib Tablets Sales by Type (2018-2029)
7.1.2 Europe Tofacitinib Tablets Revenue by Type (2018-2029)
7.2 Europe Tofacitinib Tablets Market Size by Application
7.2.1 Europe Tofacitinib Tablets Sales by Application (2018-2029)
7.2.2 Europe Tofacitinib Tablets Revenue by Application (2018-2029)
7.3 Europe Tofacitinib Tablets Market Size by Country
7.3.1 Europe Tofacitinib Tablets Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Tofacitinib Tablets Sales by Country (2018-2029)
7.3.3 Europe Tofacitinib Tablets Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Tofacitinib Tablets Market Size
8.1.1 China Tofacitinib Tablets Sales (2018-2029)
8.1.2 China Tofacitinib Tablets Revenue (2018-2029)
8.2 China Tofacitinib Tablets Market Size by Application
8.2.1 China Tofacitinib Tablets Sales by Application (2018-2029)
8.2.2 China Tofacitinib Tablets Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Tofacitinib Tablets Market Size by Type
9.1.1 Asia Tofacitinib Tablets Sales by Type (2018-2029)
9.1.2 Asia Tofacitinib Tablets Revenue by Type (2018-2029)
9.2 Asia Tofacitinib Tablets Market Size by Application
9.2.1 Asia Tofacitinib Tablets Sales by Application (2018-2029)
9.2.2 Asia Tofacitinib Tablets Revenue by Application (2018-2029)
9.3 Asia Tofacitinib Tablets Sales by Region
9.3.1 Asia Tofacitinib Tablets Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Tofacitinib Tablets Revenue by Region (2018-2029)
9.3.3 Asia Tofacitinib Tablets Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Tofacitinib Tablets Market Size by Type
10.1.1 Middle East, Africa and Latin America Tofacitinib Tablets Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Tofacitinib Tablets Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Tofacitinib Tablets Market Size by Application
10.2.1 Middle East, Africa and Latin America Tofacitinib Tablets Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Tofacitinib Tablets Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Tofacitinib Tablets Sales by Country
10.3.1 Middle East, Africa and Latin America Tofacitinib Tablets Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Tofacitinib Tablets Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Tofacitinib Tablets Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Tofacitinib Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Tofacitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Globe Pharmaceuticals
11.2.1 Globe Pharmaceuticals Company Information
11.2.2 Globe Pharmaceuticals Overview
11.2.3 Globe Pharmaceuticals Tofacitinib Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Globe Pharmaceuticals Tofacitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Globe Pharmaceuticals Recent Developments
11.3 Delta Pharma Limited
11.3.1 Delta Pharma Limited Company Information
11.3.2 Delta Pharma Limited Overview
11.3.3 Delta Pharma Limited Tofacitinib Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Delta Pharma Limited Tofacitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Delta Pharma Limited Recent Developments
11.4 Beacon Pharmaceuticals
11.4.1 Beacon Pharmaceuticals Company Information
11.4.2 Beacon Pharmaceuticals Overview
11.4.3 Beacon Pharmaceuticals Tofacitinib Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Beacon Pharmaceuticals Tofacitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Beacon Pharmaceuticals Recent Developments
11.5 Drug International
11.5.1 Drug International Company Information
11.5.2 Drug International Overview
11.5.3 Drug International Tofacitinib Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Drug International Tofacitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Drug International Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tofacitinib Tablets Industry Chain Analysis
12.2 Tofacitinib Tablets Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tofacitinib Tablets Production Mode & Process
12.4 Tofacitinib Tablets Sales and Marketing
12.4.1 Tofacitinib Tablets Sales Channels
12.4.2 Tofacitinib Tablets Distributors
12.5 Tofacitinib Tablets Customers
13 Market Dynamics
13.1 Tofacitinib Tablets Industry Trends
13.2 Tofacitinib Tablets Market Drivers
13.3 Tofacitinib Tablets Market Challenges
13.4 Tofacitinib Tablets Market Restraints
14 Key Findings in The Global Tofacitinib Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Tofacitinib Tablets Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 5mg60 Tablets
Table 3. Major Manufacturers of 5mg10 Tablets
Table 4. Major Manufacturers of 10mg10 Tablets
Table 5. Major Manufacturers of 5mg30 Tablets
Table 6. Major Manufacturers of 5mg14 Tablets
Table 7. Major Manufacturers of 10mg14 Tablets
Table 8. Global Tofacitinib Tablets Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Tofacitinib Tablets Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Tofacitinib Tablets Revenue by Region (2018-2024) & (US$ Million)
Table 11. Global Tofacitinib Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 12. Global Tofacitinib Tablets Revenue Market Share by Region (2018-2024)
Table 13. Global Tofacitinib Tablets Revenue Market Share by Region (2024-2029)
Table 14. Global Tofacitinib Tablets Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 15. Global Tofacitinib Tablets Sales by Region (2018-2024) & (K Units)
Table 16. Global Tofacitinib Tablets Sales by Region (2024-2029) & (K Units)
Table 17. Global Tofacitinib Tablets Sales Market Share by Region (2018-2024)
Table 18. Global Tofacitinib Tablets Sales Market Share by Region (2024-2029)
Table 19. Global Tofacitinib Tablets Sales by Manufacturers (2018-2024) & (K Units)
Table 20. Global Tofacitinib Tablets Sales Share by Manufacturers (2018-2024)
Table 21. Global Tofacitinib Tablets Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 22. Global Tofacitinib Tablets Revenue Share by Manufacturers (2018-2024)
Table 23. Global Key Players of Tofacitinib Tablets, Industry Ranking, 2021 VS 2022 VS 2024
Table 24. Tofacitinib Tablets Price by Manufacturers 2018-2024 (US$/Unit)
Table 25. Global Tofacitinib Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Tofacitinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tofacitinib Tablets as of 2022)
Table 27. Global Key Manufacturers of Tofacitinib Tablets, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Tofacitinib Tablets, Product Offered and Application
Table 29. Global Key Manufacturers of Tofacitinib Tablets, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Tofacitinib Tablets Sales by Type (2018-2024) & (K Units)
Table 32. Global Tofacitinib Tablets Sales by Type (2024-2029) & (K Units)
Table 33. Global Tofacitinib Tablets Sales Share by Type (2018-2024)
Table 34. Global Tofacitinib Tablets Sales Share by Type (2024-2029)
Table 35. Global Tofacitinib Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 36. Global Tofacitinib Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 37. Global Tofacitinib Tablets Revenue Share by Type (2018-2024)
Table 38. Global Tofacitinib Tablets Revenue Share by Type (2024-2029)
Table 39. Tofacitinib Tablets Price by Type (2018-2024) & (US$/Unit)
Table 40. Global Tofacitinib Tablets Price Forecast by Type (2024-2029) & (US$/Unit)
Table 41. Global Tofacitinib Tablets Sales by Application (2018-2024) & (K Units)
Table 42. Global Tofacitinib Tablets Sales by Application (2024-2029) & (K Units)
Table 43. Global Tofacitinib Tablets Sales Share by Application (2018-2024)
Table 44. Global Tofacitinib Tablets Sales Share by Application (2024-2029)
Table 45. Global Tofacitinib Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 46. Global Tofacitinib Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 47. Global Tofacitinib Tablets Revenue Share by Application (2018-2024)
Table 48. Global Tofacitinib Tablets Revenue Share by Application (2024-2029)
Table 49. Tofacitinib Tablets Price by Application (2018-2024) & (US$/Unit)
Table 50. Global Tofacitinib Tablets Price Forecast by Application (2024-2029) & (US$/Unit)
Table 51. US & Canada Tofacitinib Tablets Sales by Type (2018-2024) & (K Units)
Table 52. US & Canada Tofacitinib Tablets Sales by Type (2024-2029) & (K Units)
Table 53. US & Canada Tofacitinib Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 54. US & Canada Tofacitinib Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 55. US & Canada Tofacitinib Tablets Sales by Application (2018-2024) & (K Units)
Table 56. US & Canada Tofacitinib Tablets Sales by Application (2024-2029) & (K Units)
Table 57. US & Canada Tofacitinib Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 58. US & Canada Tofacitinib Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 59. US & Canada Tofacitinib Tablets Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 60. US & Canada Tofacitinib Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 61. US & Canada Tofacitinib Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 62. US & Canada Tofacitinib Tablets Sales by Country (2018-2024) & (K Units)
Table 63. US & Canada Tofacitinib Tablets Sales by Country (2024-2029) & (K Units)
Table 64. Europe Tofacitinib Tablets Sales by Type (2018-2024) & (K Units)
Table 65. Europe Tofacitinib Tablets Sales by Type (2024-2029) & (K Units)
Table 66. Europe Tofacitinib Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Tofacitinib Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Tofacitinib Tablets Sales by Application (2018-2024) & (K Units)
Table 69. Europe Tofacitinib Tablets Sales by Application (2024-2029) & (K Units)
Table 70. Europe Tofacitinib Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Tofacitinib Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Tofacitinib Tablets Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Tofacitinib Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Tofacitinib Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Tofacitinib Tablets Sales by Country (2018-2024) & (K Units)
Table 76. Europe Tofacitinib Tablets Sales by Country (2024-2029) & (K Units)
Table 77. China Tofacitinib Tablets Sales by Type (2018-2024) & (K Units)
Table 78. China Tofacitinib Tablets Sales by Type (2024-2029) & (K Units)
Table 79. China Tofacitinib Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 80. China Tofacitinib Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 81. China Tofacitinib Tablets Sales by Application (2018-2024) & (K Units)
Table 82. China Tofacitinib Tablets Sales by Application (2024-2029) & (K Units)
Table 83. China Tofacitinib Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 84. China Tofacitinib Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 85. Asia Tofacitinib Tablets Sales by Type (2018-2024) & (K Units)
Table 86. Asia Tofacitinib Tablets Sales by Type (2024-2029) & (K Units)
Table 87. Asia Tofacitinib Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 88. Asia Tofacitinib Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 89. Asia Tofacitinib Tablets Sales by Application (2018-2024) & (K Units)
Table 90. Asia Tofacitinib Tablets Sales by Application (2024-2029) & (K Units)
Table 91. Asia Tofacitinib Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 92. Asia Tofacitinib Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 93. Asia Tofacitinib Tablets Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 94. Asia Tofacitinib Tablets Revenue by Region (2018-2024) & (US$ Million)
Table 95. Asia Tofacitinib Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 96. Asia Tofacitinib Tablets Sales by Region (2018-2024) & (K Units)
Table 97. Asia Tofacitinib Tablets Sales by Region (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Tofacitinib Tablets Sales by Type (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Tofacitinib Tablets Sales by Type (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Tofacitinib Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Tofacitinib Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Tofacitinib Tablets Sales by Application (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Tofacitinib Tablets Sales by Application (2024-2029) & (K Units)
Table 104. Middle East, Africa and Latin America Tofacitinib Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Tofacitinib Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Tofacitinib Tablets Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 107. Middle East, Africa and Latin America Tofacitinib Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Tofacitinib Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Tofacitinib Tablets Sales by Country (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Tofacitinib Tablets Sales by Country (2024-2029) & (K Units)
Table 111. Pfizer Company Information
Table 112. Pfizer Description and Major Businesses
Table 113. Pfizer Tofacitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 114. Pfizer Tofacitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Pfizer Recent Developments
Table 116. Globe Pharmaceuticals Company Information
Table 117. Globe Pharmaceuticals Description and Major Businesses
Table 118. Globe Pharmaceuticals Tofacitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 119. Globe Pharmaceuticals Tofacitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Globe Pharmaceuticals Recent Developments
Table 121. Delta Pharma Limited Company Information
Table 122. Delta Pharma Limited Description and Major Businesses
Table 123. Delta Pharma Limited Tofacitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 124. Delta Pharma Limited Tofacitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Delta Pharma Limited Recent Developments
Table 126. Beacon Pharmaceuticals Company Information
Table 127. Beacon Pharmaceuticals Description and Major Businesses
Table 128. Beacon Pharmaceuticals Tofacitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 129. Beacon Pharmaceuticals Tofacitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Beacon Pharmaceuticals Recent Developments
Table 131. Drug International Company Information
Table 132. Drug International Description and Major Businesses
Table 133. Drug International Tofacitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 134. Drug International Tofacitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Drug International Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Tofacitinib Tablets Distributors List
Table 139. Tofacitinib Tablets Customers List
Table 140. Tofacitinib Tablets Market Trends
Table 141. Tofacitinib Tablets Market Drivers
Table 142. Tofacitinib Tablets Market Challenges
Table 143. Tofacitinib Tablets Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Tofacitinib Tablets Product Picture
Figure 2. Global Tofacitinib Tablets Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Tofacitinib Tablets Market Share by Type in 2022 & 2029
Figure 4. 5mg60 Tablets Product Picture
Figure 5. 5mg10 Tablets Product Picture
Figure 6. 10mg10 Tablets Product Picture
Figure 7. 5mg30 Tablets Product Picture
Figure 8. 5mg14 Tablets Product Picture
Figure 9. 10mg14 Tablets Product Picture
Figure 10. Global Tofacitinib Tablets Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Tofacitinib Tablets Market Share by Application in 2022 & 2029
Figure 12. Rheumatoid Arthritis
Figure 13. Ulcerative Colitis
Figure 14. Psoriasis
Figure 15. Other
Figure 16. Tofacitinib Tablets Report Years Considered
Figure 17. Global Tofacitinib Tablets Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Tofacitinib Tablets Revenue 2018-2029 (US$ Million)
Figure 19. Global Tofacitinib Tablets Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 20. Global Tofacitinib Tablets Revenue Market Share by Region (2018-2029)
Figure 21. Global Tofacitinib Tablets Sales 2018-2029 ((K Units)
Figure 22. Global Tofacitinib Tablets Sales Market Share by Region (2018-2029)
Figure 23. US & Canada Tofacitinib Tablets Sales YoY (2018-2029) & (K Units)
Figure 24. US & Canada Tofacitinib Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Europe Tofacitinib Tablets Sales YoY (2018-2029) & (K Units)
Figure 26. Europe Tofacitinib Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 27. China Tofacitinib Tablets Sales YoY (2018-2029) & (K Units)
Figure 28. China Tofacitinib Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Asia (excluding China) Tofacitinib Tablets Sales YoY (2018-2029) & (K Units)
Figure 30. Asia (excluding China) Tofacitinib Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Tofacitinib Tablets Sales YoY (2018-2029) & (K Units)
Figure 32. Middle East, Africa and Latin America Tofacitinib Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 33. The Tofacitinib Tablets Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 34. The Top 5 and 10 Largest Manufacturers of Tofacitinib Tablets in the World: Market Share by Tofacitinib Tablets Revenue in 2022
Figure 35. Global Tofacitinib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Tofacitinib Tablets Sales Market Share by Type (2018-2029)
Figure 37. Global Tofacitinib Tablets Revenue Market Share by Type (2018-2029)
Figure 38. Global Tofacitinib Tablets Sales Market Share by Application (2018-2029)
Figure 39. Global Tofacitinib Tablets Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Tofacitinib Tablets Sales Market Share by Type (2018-2029)
Figure 41. US & Canada Tofacitinib Tablets Revenue Market Share by Type (2018-2029)
Figure 42. US & Canada Tofacitinib Tablets Sales Market Share by Application (2018-2029)
Figure 43. US & Canada Tofacitinib Tablets Revenue Market Share by Application (2018-2029)
Figure 44. US & Canada Tofacitinib Tablets Revenue Share by Country (2018-2029)
Figure 45. US & Canada Tofacitinib Tablets Sales Share by Country (2018-2029)
Figure 46. U.S. Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 47. Canada Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 48. Europe Tofacitinib Tablets Sales Market Share by Type (2018-2029)
Figure 49. Europe Tofacitinib Tablets Revenue Market Share by Type (2018-2029)
Figure 50. Europe Tofacitinib Tablets Sales Market Share by Application (2018-2029)
Figure 51. Europe Tofacitinib Tablets Revenue Market Share by Application (2018-2029)
Figure 52. Europe Tofacitinib Tablets Revenue Share by Country (2018-2029)
Figure 53. Europe Tofacitinib Tablets Sales Share by Country (2018-2029)
Figure 54. Germany Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 55. France Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 56. U.K. Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 57. Italy Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 58. Russia Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 59. China Tofacitinib Tablets Sales Market Share by Type (2018-2029)
Figure 60. China Tofacitinib Tablets Revenue Market Share by Type (2018-2029)
Figure 61. China Tofacitinib Tablets Sales Market Share by Application (2018-2029)
Figure 62. China Tofacitinib Tablets Revenue Market Share by Application (2018-2029)
Figure 63. Asia Tofacitinib Tablets Sales Market Share by Type (2018-2029)
Figure 64. Asia Tofacitinib Tablets Revenue Market Share by Type (2018-2029)
Figure 65. Asia Tofacitinib Tablets Sales Market Share by Application (2018-2029)
Figure 66. Asia Tofacitinib Tablets Revenue Market Share by Application (2018-2029)
Figure 67. Asia Tofacitinib Tablets Revenue Share by Region (2018-2029)
Figure 68. Asia Tofacitinib Tablets Sales Share by Region (2018-2029)
Figure 69. Japan Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 70. South Korea Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 71. China Taiwan Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 72. Southeast Asia Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 73. India Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Tofacitinib Tablets Sales Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Tofacitinib Tablets Revenue Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America Tofacitinib Tablets Sales Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Tofacitinib Tablets Revenue Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America Tofacitinib Tablets Revenue Share by Country (2018-2029)
Figure 79. Middle East, Africa and Latin America Tofacitinib Tablets Sales Share by Country (2018-2029)
Figure 80. Brazil Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 81. Mexico Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 82. Turkey Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 83. Israel Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 84. GCC Countries Tofacitinib Tablets Revenue (2018-2029) & (US$ Million)
Figure 85. Tofacitinib Tablets Value Chain
Figure 86. Tofacitinib Tablets Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

Global Tofacitinib Tablets Market Insights, Forecast to 2034

Global Tofacitinib Tablets Market Insights, Forecast to 2034

By Company

Segment by Application

Segment by Region

Chapter Outline

Table of Content

List of Figure

Select User License

$4200 Single Licence

$6000 Enterprise Licence

$9100 Corporate Licence

Note : All prices in USD

FAQ'S

User License?

Delivery Time?

How do I place an order?

What is the Payment Options?

Is there a discount for multiple purchases?

Mode of Report Delivery?

Top Industries